BMY vs PFE — Key Metrics
| Metric | BMY (Bristol-Myers Squibb Co) | PFE (Pfizer Inc) |
|---|---|---|
| Price | 65.33 | 25.020000000000003 |
| Market Cap | 133.37 Thousand | 142.54 Thousand |
| P/E (TTM) | 22.3145 | 19.0286 |
| P/B (Quarterly) | 6.1706 | 1.7532 |
| P/S (TTM) | 2.7509 | 2.2514 |
| Net Profit Margin (TTM) | 12.33 | 11.83 |
| Gross Margin (TTM) | 53.71 | 74.8 |
| ROE (TTM) | 41.64 | 8.37 |
| Revenue Growth YoY (TTM) | 1.78 | 1.36 |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with real-time market insights and portfolio modeling.
Performance Comparison
Financial Metrics
| BMY | Metrics | PFE |
|---|---|---|
| $65.33 | Price | $25.02 |
| — | Market Capitalization | — |
| 10.35 | Price to Earning Ratio | 8.64 |
| 2.76 | Price to Revenue Ratio | 2.26 |
| 1.78% | Revenue Growth | 1.36% |
| 53.71% | Gross Profit Margin | 74.8% |
| 12.33% | Net Profit Margin | 11.83% |
|
Outperform |
AI Model Recommendation |
Underperform |
Recommendation SummaryStock BMY is projected to outperform the market, stock PFE is projected to underperform the market. Upfront Recommendation: BMY. |
||
Stock Comparison
Proprietary AI Model
Proprietary AI Model
Cumulative Return Analysis
Top Holdings
| Symbol | Company | Weight |
|---|